---
title: "Glaxosmithkline Pharmaceuticals Ltd (GLAXO) — Share Price, Financials & Analysis"
symbol: "GLAXO"
company: "Glaxosmithkline Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/GLAXO"
isin: "INE159A01016"
nse_symbol: "GLAXO"
bse_code: "500660"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 47745.4
generated_at: "2026-09-13T18:19:48.740Z"
---

# Glaxosmithkline Pharmaceuticals Ltd (GLAXO)

Canonical page: https://tapetide.com/stocks/GLAXO

## Company

- **NSE Symbol:** GLAXO
- **BSE Code:** 500660
- **ISIN:** INE159A01016
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2000-12-15
- **CEO:** Mr. Bhushan Akshikar
- **Employees:** 3113
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** gsk-india.com

## About

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)

## Latest Price

- **Price:** ₹2828.4
- **Change:** -12.5 (-0.44%)
- **Open:** ₹2840.9
- **Day High:** ₹2863.5
- **Day Low:** ₹2793.9
- **Previous Close:** ₹2840.9
- **Volume:** 38428
- **As Of:** 2026-09-11T10:01:42+00:00

## Key Fundamentals

Observed at 2026-09-11T04:34:40.050491Z.

- **Market Cap:** ₹47745.4 Cr
- **Classification:** Midcap
- **P/E (reported):** 45.1
- **P/E (TTM):** 44.86
- **EPS (TTM):** ₹63.05
- **EPS (reported):** ₹45.47
- **Book Value:** ₹133.85
- **Price to Book:** 21.22
- **Dividend Yield:** 2.01%
- **ROE:** 45.69%
- **ROCE:** 55.36%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹3967 Cr
- **Net Income:** ₹1036 Cr
- **EBITDA:** ₹1454.6 Cr
- **52-Week High:** ₹3120.7
- **52-Week Low:** ₹2088.1
- **RSI (14):** 48.58

## Tapetide Score

- **Score:** 58 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Falling
- **Percentile:** 81.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 84.35 | 9% |
| growth | 14.31 | 9% |
| momentum | 46.12 | 12% |
| ownership | 50.79 | 24% |
| quality | 84.47 | 22% |
| valuation | 52.75 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 43.5%
- Company has been maintaining a healthy dividend payout of 94.6%

### Weaknesses

- Stock is trading at 21.1 times its book value
- The company has delivered a poor sales growth of 5.49% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -29.97% | 55.2% | 11.42% |
| ebitda margin growth | -12.3% | 7.95% | 27.15% | 46.8% |
| net income growth | -14.65% | 11.69% | 18% | 15% |
| revenue growth | -4.75% | 1.85% | 6% | 5% |
| roce | -13.46% | -3.3% | 37.51% | 44.28% |
| roe | -14.64% | -3.89% | 42.14% | 219.51% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 957 | 805 | 930 | 815 | 1011 | 949 | 974 | 805 | 980 | 1041 | 995 | 938 |
| Expenses | 668 | 587 | 673 | 584 | 689 | 658 | 641 | 554 | 644 | 670 | 644 | 643 |
| Operating Profit | 289 | 218 | 257 | 231 | 322 | 292 | 333 | 251 | 336 | 371 | 351 | 296 |
| OPM % | 30 | 27 | 28 | 28 | 32 | 31 | 34 | 31 | 34 | 36 | 35 | 31 |
| Other Income | 28 | -135 | 32 | 36 | 39 | 35 | 41 | 44 | 36 | 50 | 36 | 44 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 18 | 17 | 18 | 16 | 17 | 19 | 15 | 16 | 17 | 20 | 13 | 16 |
| Profit before tax | 299 | 65 | 271 | 249 | 344 | 308 | 359 | 279 | 354 | 400 | 373 | 322 |
| Tax % | 27 | 30 | 28 | 27 | 27 | 25 | 27 | 27 | 27 | 26 | 26 | 26 |
| Net Profit | 218 | 46 | 194 | 182 | 252 | 230 | 263 | 205 | 257 | 296 | 278 | 237 |
| EPS in Rs | 12.84 | 2.7 | 11.48 | 10.76 | 14.91 | 13.57 | 15.52 | 12.1 | 15.2 | 17.45 | 16.4 | 14 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2871 | 3128 | 3224 | 2926 | 3278 | 3252 | 3454 | 3749 | 3822 | 3955 |
| Expenses | 2363 | 2527 | 2567 | 2327 | 2516 | 2447 | 2545 | 2570 | 2512 | 2601 |
| Operating Profit | 508 | 601 | 657 | 598 | 762 | 804 | 909 | 1179 | 1309 | 1354 |
| OPM % | 18 | 19 | 20 | 20 | 23 | 25 | 26 | 31 | 34 | 34 |
| Other Income | 70 | 131 | -262 | 9 | 1401 | 103 | -21 | 149 | 166 | 166 |
| Interest | 0 | 1 | 6 | 4 | 2 | 2 | 2 | 1 | 3 | 3 |
| Depreciation | 38 | 49 | 83 | 79 | 68 | 66 | 70 | 67 | 66 | 67 |
| Profit before tax | 540 | 683 | 306 | 525 | 2093 | 839 | 816 | 1260 | 1406 | 1449 |
| Tax % | 35 | 35 | 70 | 32 | 19 | 27 | 28 | 26 | 26 | — |
| Net Profit | 351 | 445 | 93 | 358 | 1695 | 611 | 590 | 928 | 1036 | 1068 |
| EPS in Rs | 20.7 | 26.29 | 5.5 | 21.14 | 100.04 | 36.05 | 34.83 | 54.75 | 61.15 | 63.05 |
| Dividend Payout % | 85 | 76 | 727 | 142 | 90 | 89 | 92 | 99 | 93 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 85 | 85 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 |
| Reserves | 1922 | 1973 | 1970 | 1651 | 1309 | 2494 | 1572 | 1608 | 1782 | 2098 |
| Borrowings | 2 | 1 | 1 | 0 | 35 | 20 | 16 | 19 | 10 | 33 |
| Other Liabilities | 995 | 1889 | 1771 | 1315 | 1602 | 1950 | 1570 | 1760 | 2147 | 2023 |
| Total Liabilities | 3004 | 3947 | 3911 | 3136 | 3115 | 4633 | 3327 | 3557 | 4108 | 4324 |
| Fixed Assets | 258 | 325 | 432 | 758 | 387 | 331 | 330 | 321 | 284 | 281 |
| CWIP | 605 | 923 | 1003 | 120 | 13 | 30 | 20 | 14 | 14 | 33 |
| Investments | 0 | 0 | 0 | 0 | 0 | 366 | 518 | 813 | 1118 | 1392 |
| Other Assets | 2140 | 2700 | 2477 | 2257 | 2715 | 3907 | 2458 | 2408 | 2692 | 2618 |
| Total Assets | 3004 | 3947 | 3911 | 3136 | 3115 | 4633 | 3327 | 3557 | 4108 | 4324 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 234 | 473 | 409 | 490 | 578 | 811 | 484 | 582 | 1290 | 903 |
| Cash from Investing Activity | 301 | -104 | -153 | -57 | 418 | -406 | 808 | 9 | -46 | 397 |
| Cash from Financing Activity | -511 | -307 | -358 | -428 | -696 | -524 | -1543 | -562 | -769 | -737 |
| Net Cash Flow | 24 | 62 | -102 | 6 | 300 | -119 | -251 | 29 | 475 | 563 |
| Free Cash Flow | -24 | 639 | 166 | 336 | 536 | 2371 | 451 | 573 | 1273 | 870 |
| CFO/OP | 94 | 133 | 101 | 103 | 121 | 122 | 93 | 92 | 116 | 93 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 21 | 19 | 14 | 11 | 27 | 23 | 22 | 23 | 28 | 26 |
| Inventory Days | 111 | 147 | 131 | 135 | 159 | 144 | 131 | 144 | 126 | 124 |
| Days Payable | 73 | 149 | 109 | 100 | 135 | 156 | 122 | 171 | 186 | 154 |
| Cash Conversion Cycle | 60 | 17 | 36 | 46 | 50 | 11 | 31 | -4 | -31 | -4 |
| Working Capital Days | 7 | -90 | -72 | -38 | -39 | -94 | -57 | -64 | -99 | -91 |
| ROCE % | 22 | 26 | 31 | 33 | 38 | 37 | 36 | 51 | 63 | 61 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% |
| FIIs | 2.5% | 2.93% | 3.48% | 4.02% | 4.36% | 4.5% | 4.52% | 4.89% | 4.8% | 4.64% | 4.62% | 4.79% |
| DIIs | 10.01% | 8.53% | 7.9% | 7.5% | 7.34% | 7.3% | 7.79% | 7.7% | 7.75% | 7.7% | 7.68% | 7.8% |
| Government | 0.01% | 0.01% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 10.62% | 11.08% | 11.27% | 11.15% | 10.97% | 10.96% | 10.6% | 10.32% | 10.34% | 10.36% | 10.35% | 10.21% |
| Others | 1.87% | 2.45% | 2.35% | 2.33% | 2.33% | 2.23% | 2.09% | 2.09% | 2.11% | 2.3% | 2.35% | 2.2% |
| No. of Shareholders | 115266 | 114663 | 118994 | 118515 | 119228 | 119625 | 121885 | 123629 | 122904 | 122460 | 121763 | 126087 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 2 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 2933.72 | Sell |
| EMA (10) | 2908.17 | Sell |
| SMA (20) | 2947.84 | Sell |
| EMA (20) | 2888.2 | Sell |
| SMA (50) | 2704.99 | Buy |
| EMA (50) | 2743.9 | Buy |
| SMA (100) | 2516.92 | Buy |
| EMA (100) | 2620.26 | Buy |
| SMA (200) | 2491.35 | Buy |
| EMA (200) | 2582.74 | Buy |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.43 | Neutral |
| MACD (12,26,9) | 51.31 | Sell |
| Stochastic (14,3,3) | 7.76 | Buy |
| ADX (14) | 32.11 | Buy |
| Williams %R (14) | -89.44 | Buy |
| ATR (14) | 87.51 | High Volatility |
| ROC (12) | -6.79 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 29.57 | Buy |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 3 | 75% |
| Hold | 1 | 25% |
| Sell | 0 | 0% |

Based on 4 analyst ratings, observed at 2026-09-11T04:34:40.047248+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb3277ba-4b47-4b4a-b4fa-a8fc3a9d9207.pdf) |
| 2026-09-01 | [Corrigendum To The Notice Of Postal Ballot Dated August 3 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b514e6a1-d5d5-4639-8152-b3b8d0392850.pdf) |
| 2026-08-26 | [Volume Movement Letter](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=802f4ef8-514d-4b10-b78f-f4bab8235fff.pdf) |
| 2026-08-19 | [Disclosure Under Regulation 30](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d352cfd-c11e-4db7-8ed0-93d694b25357.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dab208ac-9ed9-4cb8-bd7e-6eaa811c9fde.pdf) |
| 2026-08-13 | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9fcd9ea-6b5d-4fd7-a562-4037ddfbd4b8.pdf) |
| 2026-08-06 | [Disclosure Under Regulation 30](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bff88681-ee5d-4af0-8635-7d3a8936bfeb.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78f2a689-8bf2-44e6-8bbc-8d2799100e40.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cca60b47-c4a5-42a9-baba-903e51c7d773.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ff53b6e-585e-4e2e-92f7-6da4178a3bfd.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Mar - Postal ballot to appoint Ronojit Biswas as Whole‑time Director & CFO (1Apr2026–31Mar2029); salary up to Rs16L/month; Rs20L sign‑on. | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 7 Mar - Postal ballot to appoint Ronojit Biswas as Whole‑time Director & CFO (1Apr2026–31Mar2029); salary up to Rs16L/month; Rs20L sign‑on.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cb41135f-90aa-4166-ac59-e237e0065f87.pdf) |
| 7 Mar - Maharashtra GST order (Apr 2022–Mar 2023) demanding Rs.6,92,76,478 (tax+penalty); interest unquantified. | [Disclosure Under Regulations 30 7 Mar - Maharashtra GST order (Apr 2022–Mar 2023) demanding Rs.6,92,76,478 (tax+penalty); interest unquantified.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/638309ce-842e-4e89-b08f-9388f3e414e0.pdf) |
| 7 Mar - Appoint Ronojit Biswas as Whole-time Director & CFO from 1 April 2026 for three years; salary up to Rs16 lakh/month. | [Postal Ballot Notice 7 Mar - Appoint Ronojit Biswas as Whole-time Director & CFO from 1 April 2026 for three years; salary up to Rs16 lakh/month.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f73f6e40-b8e6-48bc-a547-94143970dcd7.pdf) |
| 31 Mar - TDS assessment order dated 31-Mar-2026: demand Rs 2.01 Cr (TDS Rs1.11Cr, interest Rs0.90Cr); company will appeal. | [Disclosure Under Regulation 30 31 Mar - TDS assessment order dated 31-Mar-2026: demand Rs 2.01 Cr (TDS Rs1.11Cr, interest Rs0.90Cr); company will appeal.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2ee5987-a09e-472e-ad42-f1a4423a8d1a.pdf) |
| 24 Mar - Assessment order (23 Mar 2026) issued; Rs 23.21 Crore demand for AY 2023-24; company to appeal. | [Disclosure Under Regulation 30 24 Mar - Assessment order (23 Mar 2026) issued; Rs 23.21 Crore demand for AY 2023-24; company to appeal.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4e212121-37e9-4764-9235-0f4702db31e1.pdf) |
| 22 Apr - Publication of special window for share transfer and Saksham Niveshak Campaign | [Announcement under Regulation 30 (LODR)-Newspaper Publication 22 Apr - Publication of special window for share transfer and Saksham Niveshak Campaign](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8c1e8c4f-8afc-449c-a542-9a2c60d40a4c.pdf) |
| 22 Apr - Board meets 13 May 2026 to consider audited FY26 results and dividend recommendation. | [Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Year Ended 31St March 2026 And Dividend If Any 22 Apr - Board meets 13 May 2026 to consider audited FY26 results and dividend recommendation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ba697111-e184-437a-81df-9c13fee2ff15.pdf) |
| 21 Apr - Vinay Subramanian joins GSK leadership team and senior management effective 20 April 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 21 Apr - Vinay Subramanian joins GSK leadership team and senior management effective 20 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1af31c2d-4e7d-4bbd-9d7b-78c7ed6b3ac0.pdf) |
| 21 Apr - GSK authorizes four officials to determine materiality disclosures under Regulation 30(5). | [Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 21 Apr - GSK authorizes four officials to determine materiality disclosures under Regulation 30(5).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dcdb3e3c-8b6e-462c-bcc4-43ee0852ea69.pdf) |
| 2 Mar - Ronojit Biswas appointed Whole-Time Director & CFO effective 1 April 2026; Juby Chandy steps down 11 March 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 2 Mar - Ronojit Biswas appointed Whole-Time Director & CFO effective 1 April 2026; Juby Chandy steps down 11 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/51a12287-3d8b-4a30-b65f-9cfa0cc14950.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-03 | [Results For Quarter 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f2fec72-2911-46fb-ba6a-fededf51a048.pdf) |
| 2026-05-13 | [Outcome Of Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f3be2e0-d52e-4e28-b4a0-83fa58c03bba.pdf) |
| 2026-02-09 | [Financial Results For Quarter & Nine Months December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80302ab0-7804-492b-ae4c-f7cddcc92967.pdf) |
| 2025-11-06 | [Results Ended Quater September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6265993f-3554-4004-9d0a-2861effa6779.pdf) |
| 2025-08-01 | [Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1382030-78c7-4eef-a7c3-867ae9fd65b6.pdf) |
| 2025-05-13 | [Outcome Of Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4590c00b-921d-4566-aed5-22db996e0397.pdf) |
| 2025-02-14 | [Ouctome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c890f688-407a-4563-be7f-47717ba8ddd0.pdf) |
| 2024-10-29 | [Un Audited Financials Results For Quarter & Half Year Ended 30Th September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d91ea356-37e8-40ac-b25f-2ecf13939fb2.pdf) |
| 2024-08-02 | [Financials Results For June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735f41ff-ff4e-4ea2-a3ca-421fb7cd0ff4.pdf) |
| 2024-05-17 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe7defcb-06e2-4078-94ea-6d00b87116e8.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50c88077-6708-452c-8af2-08dd1c068980.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/50c88077-6708-452c-8af2-08dd1c068980.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59ebf753-033f-40f4-ac54-fa8b6e063f12.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b1b5717-5cc7-45fd-afc7-042cbfca5680.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8b1b5717-5cc7-45fd-afc7-042cbfca5680.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5100e2c6-6403-42f0-9a36-3733c85a2d13.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ad14593-1179-49a4-820c-f5a9a3321097.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5100e2c6-6403-42f0-9a36-3733c85a2d13.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ad14593-1179-49a4-820c-f5a9a3321097.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5466c9ee-0adb-445b-bdff-af657cc85fc1.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3217_GLAXO_2013_2013_24032014174919.zip) |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_347_GLAXO_2012_2012_05072013102200.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce145150-b925-4d9e-b915-b720c933a8c8.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72fcf18f-8def-4198-9977-dfc64762d12c.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08dba7e9-e85f-4c3d-a358-178b1d8c499c.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b6b29ed5-b0b2-40db-aa46-3efc83311bb8.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/73292500660.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/68671500660.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/5006600320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500660/5006600319.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59ebf753-033f-40f4-ac54-fa8b6e063f12.pdf) |
| 2025-08-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11959022-3697-4e9d-9517-932286dd43f6.pdf) |
| 2025-05-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c5b8816-0d2a-4289-9c0d-588f9f46e3fa.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:19:48.740Z.